Search Login Register
Fistula
Summary
Description:
Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
Also Known As:
Fistulas
Networked: 16353
relevant articles (658 outcomes,
839 trials/studies)
for this Disease
Key Drugs and Agents for Fistula
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Fibrin Tissue Adhesive (Fibrin Sealant)
:
39 outcomes 36 studies in 316 results
: IBA
-
infliximab (Remicade)
:
37 outcomes 26 studies in 134 results
:
FDA 2
-
Octreotide (Sandostatin)
:
17 outcomes 13 studies in 105 results
:
FDA 14
Generic
-
Somatostatin (Somatotropin Release-Inhibiting Factor)
:
12 outcomes 15 studies in 141 results
: IBA
-
adalimumab (Humira)
:
12 outcomes 5 studies in 35 results
:
FDA 2
-
Anti-Bacterial Agents (Antibiotics)
:
9 outcomes 13 studies in 161 results
: IBA
-
alpha-Fetoproteins (AFP)
:
7 outcomes 6 studies in 19 results
: IBA
-
Phenobarbital (Luminal)
:
7 outcomes 4 studies in 64 results
:
FDA 1
-
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
:
7 outcomes 2 studies in 38 results
: IBA
-
Collagen
:
6 outcomes 5 studies in 88 results
: IBA
Show All >>
Diseases Related to Fistula
-
Crohn Disease (Crohn's Disease)
-
Fistula
-
Pathologic Constriction (Stenosis)
-
Infection
-
Rectal Fistula (Anal Fistula)
Show All >>
Key Therapies for Fistula
Efficacy Chart >>
-
Stents
:
74 outcomes 29 studies in 1188 results
-
Transplants (Transplant)
:
64 outcomes 98 studies in 1989 results
-
Ligation
:
34 outcomes 25 studies in 604 results
-
Renal Dialysis (Hemodialysis)
:
31 outcomes 65 studies in 888 results
-
Catheters
:
23 outcomes 45 studies in 1084 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.